133 related articles for article (PubMed ID: 32491288)
1. Betanin effect on PPAR-α and SREBP-1c expression in NMRI mice model of steatohepatitis with fibrosis.
Yahaghi L; Yaghmaei P; Hayati-Roodbari N; Irani S; Ebrahim-Habibi A
Physiol Int; 2020 Mar; 107(1):67-81. PubMed ID: 32491288
[TBL] [Abstract][Full Text] [Related]
2. The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α.
Ren T; Zhu J; Zhu L; Cheng M
Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264426
[TBL] [Abstract][Full Text] [Related]
3. Preventive effect of trans-chalcone on non-alcoholic steatohepatitis: Improvement of hepatic lipid metabolism.
Karimi-Sales E; Ebrahimi-Kalan A; Alipour MR
Biomed Pharmacother; 2019 Jan; 109():1306-1312. PubMed ID: 30551380
[TBL] [Abstract][Full Text] [Related]
4. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
5. Overproduction of altered VLDL in an insulin-resistance rat model: Influence of SREBP-1c and PPAR-α.
Lucero D; Miksztowicz V; Macri V; López GH; Friedman S; Berg G; Zago V; Schreier L
Clin Investig Arterioscler; 2015; 27(4):167-74. PubMed ID: 25796423
[TBL] [Abstract][Full Text] [Related]
6. Chrysin ameliorates nonalcoholic fatty liver disease in rats.
Pai SA; Munshi RP; Panchal FH; Gaur IS; Juvekar AR
Naunyn Schmiedebergs Arch Pharmacol; 2019 Dec; 392(12):1617-1628. PubMed ID: 31372694
[TBL] [Abstract][Full Text] [Related]
7. Antrodan Alleviates High-Fat and High-Fructose Diet-Induced Fatty Liver Disease in C57BL/6 Mice Model via AMPK/Sirt1/SREBP-1c/PPARγ Pathway.
Chyau CC; Wang HF; Zhang WJ; Chen CC; Huang SH; Chang CC; Peng RY
Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31935815
[TBL] [Abstract][Full Text] [Related]
8. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
[TBL] [Abstract][Full Text] [Related]
9. Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion.
Pettinelli P; Del Pozo T; Araya J; Rodrigo R; Araya AV; Smok G; Csendes A; Gutierrez L; Rojas J; Korn O; Maluenda F; Diaz JC; Rencoret G; Braghetto I; Castillo J; Poniachik J; Videla LA
Biochim Biophys Acta; 2009 Nov; 1792(11):1080-6. PubMed ID: 19733654
[TBL] [Abstract][Full Text] [Related]
10. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
Malhotra P; Aloman C; Ankireddy A; Khadra H; Ooka K; Gill RK; Saksena S; Dudeja PK; Alrefai WA
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G376-G385. PubMed ID: 28774869
[TBL] [Abstract][Full Text] [Related]
11. Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression.
Abd El-Haleim EA; Bahgat AK; Saleh S
Eur J Pharmacol; 2016 Feb; 773():59-70. PubMed ID: 26825546
[TBL] [Abstract][Full Text] [Related]
12. Polydatin alleviates non-alcoholic fatty liver disease in rats by inhibiting the expression of TNF-α and SREBP-1c.
Zhang J; Tan Y; Yao F; Zhang Q
Mol Med Rep; 2012 Oct; 6(4):815-20. PubMed ID: 22858825
[TBL] [Abstract][Full Text] [Related]
13. The ergogenic supplement β-hydroxy-β-methylbutyrate (HMB) attenuates insulin resistance through suppressing GLUT-2 in rat liver.
Sharawy MH; El-Awady MS; Megahed N; Gameil NM
Can J Physiol Pharmacol; 2016 May; 94(5):488-97. PubMed ID: 26871756
[TBL] [Abstract][Full Text] [Related]
14. Supplementation with Docosahexaenoic Acid and Extra Virgin Olive Oil Prevents Liver Steatosis Induced by a High-Fat Diet in Mice through PPAR-α and Nrf2 Upregulation with Concomitant SREBP-1c and NF-kB Downregulation.
Hernández-Rodas MC; Valenzuela R; Echeverría F; Rincón-Cervera MÁ; Espinosa A; Illesca P; Muñoz P; Corbari A; Romero N; Gonzalez-Mañan D; Videla LA
Mol Nutr Food Res; 2017 Dec; 61(12):. PubMed ID: 28940752
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression.
Abd El-Haleim EA; Bahgat AK; Saleh S
World J Gastroenterol; 2016 Mar; 22(10):2931-48. PubMed ID: 26973390
[TBL] [Abstract][Full Text] [Related]
16. Effects of adiponectin transgenic expression in liver of nonalcoholic steatohepatitis model mice.
Nakayama H; Otabe S; Yuan X; Ueno T; Hirota N; Fukutani T; Wada N; Hashinaga T; Yamada K
Metabolism; 2009 Jul; 58(7):901-8. PubMed ID: 19394977
[TBL] [Abstract][Full Text] [Related]
17. Epoxyeicosatrienoic acids alleviate methionine-choline-deficient diet-induced non-alcoholic steatohepatitis in mice.
Wang X; Li L; Wang H; Xiao F; Ning Q
Scand J Immunol; 2019 Sep; 90(3):e12791. PubMed ID: 31132306
[TBL] [Abstract][Full Text] [Related]
18. Effect of trans-chalcone on atheroma plaque formation, liver fibrosis and adiponectin gene expression in cholesterol-fed NMRI mice.
Karkhaneh L; Yaghmaei P; Parivar K; Sadeghizadeh M; Ebrahim-Habibi A
Pharmacol Rep; 2016 Aug; 68(4):720-7. PubMed ID: 27126698
[TBL] [Abstract][Full Text] [Related]
19. Preventive Effect of Citrus aurantium Peel Extract on High-Fat Diet-Induced Non-alcoholic Fatty Liver in Mice.
Han HY; Lee SK; Choi BK; Lee DR; Lee HJ; Kim TW
Biol Pharm Bull; 2019; 42(2):255-260. PubMed ID: 30713255
[TBL] [Abstract][Full Text] [Related]
20. Reversal of high-fat diet-induced hepatic steatosis by n-3 LCPUFA: role of PPAR-α and SREBP-1c.
Dossi CG; Tapia GS; Espinosa A; Videla LA; D'Espessailles A
J Nutr Biochem; 2014 Sep; 25(9):977-84. PubMed ID: 24993917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
